Patents Assigned to Sunshine Luke Pharma Co., Ltd.
  • Spiro compounds as Hepatitis C virus inhibitors
    Patent number: 9303061
    Abstract: Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.
    Type: Grant
    Filed: July 9, 2012
    Date of Patent: April 5, 2016
    Assignee: Sunshine Luke Pharma Co., Ltd.
    Inventors: Jiancun Zhang, Yingjun Zhang, Hongming Xie, Qingyun Ren, Huichao Luo, Tianzhu Yu, Yumei Tan